den Boer JA - Search Results

1

van Megen HJ, Westenberg HG, den Boer JA, Kahn RS. van Megen HJ, et al. Among authors: den boer ja. Eur Neuropsychopharmacol. 1996 Nov;6(4):263-80. doi: 10.1016/s0924-977x(96)00038-7. Eur Neuropsychopharmacol. 1996. PMID: 8985709 Review.

2

The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder.

Bradwejn J, Koszycki D, Couëtoux du Tertre A, van Megen H, den Boer J, Westenberg H. Bradwejn J, et al. Arch Gen Psychiatry. 1994 Jun;51(6):486-93. doi: 10.1001/archpsyc.1994.03950060050005. Arch Gen Psychiatry. 1994. PMID: 8192551 Clinical Trial.

3

The MSH/ACTH analog ORG 2766 in anxiety disorders.

Den Boer JA, Westenberg HG, De Vries H. Den Boer JA, et al. Peptides. 1992 Jan-Feb;13(1):109-12. doi: 10.1016/0196-9781(92)90147-u. Peptides. 1992. PMID: 1320259 Clinical Trial.

4

Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor.

van Vliet IM, den Boer JA, Westenberg HG. van Vliet IM, et al. Among authors: den boer ja. Eur Neuropsychopharmacol. 1992 Mar;2(1):21-9. doi: 10.1016/0924-977x(92)90032-4. Eur Neuropsychopharmacol. 1992. PMID: 1638170 Clinical Trial.

5

Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients.

van Megen HJ, Westenberg HG, den Boer JA, Haigh JR, Traub M. van Megen HJ, et al. Among authors: den boer ja. Psychopharmacology (Berl). 1994 Apr;114(3):449-55. doi: 10.1007/BF02249335. Psychopharmacology (Berl). 1994. PMID: 7855203 Clinical Trial.

6

On the significance of cholecystokinin receptors in panic disorder.

van Megen HJ, den Boer JA, Westenberg HG. van Megen HJ, et al. Among authors: den boer ja. Prog Neuropsychopharmacol Biol Psychiatry. 1994 Dec;18(8):1235-46. doi: 10.1016/0278-5846(94)90090-6. Prog Neuropsychopharmacol Biol Psychiatry. 1994. PMID: 7863014 Review.

7

Behavioral, neuroendocrine and biochemical effects of different doses of 5-HTP in panic disorder.

van Vliet IM, Slaap BR, Westenberg HG, Den Boer JA. van Vliet IM, et al. Among authors: den boer ja. Eur Neuropsychopharmacol. 1996 May;6(2):103-10. doi: 10.1016/0924-977x(95)00070-6. Eur Neuropsychopharmacol. 1996. PMID: 8791035 Clinical Trial.

8

The panic-inducing properties of the cholecystokinin tetrapeptide CCK4 in patients with panic disorder.

van Megen HJ, Westenberg HG, Den Boer JA, Kahn RS. van Megen HJ, et al. Among authors: den boer ja. Eur Neuropsychopharmacol. 1996 Aug;6(3):187-94. doi: 10.1016/0924-977x(96)00018-1. Eur Neuropsychopharmacol. 1996. PMID: 8880078 Clinical Trial.

9

Effect of the cholecystokinin-B receptor antagonist L-365,260 on lactate-induced panic attacks in panic disorder patients.

van Megen HJ, Westenberg HG, den Boer JA. van Megen HJ, et al. Among authors: den boer ja. Biol Psychiatry. 1996 Oct 15;40(8):804-6. doi: 10.1016/0006-3223(96)00250-8. Biol Psychiatry. 1996. PMID: 8894076 Clinical Trial. No abstract available.

10

The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients.

van Megen HJ, Westenberg HG, den Boer JA, Slaap B, van Es-Radhakishun F, Pande AC. van Megen HJ, et al. Among authors: den boer ja. Psychopharmacology (Berl). 1997 Feb;129(3):243-8. doi: 10.1007/s002130050186. Psychopharmacology (Berl). 1997. PMID: 9084062 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters